1547 related articles for article (PubMed ID: 28058965)
21. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.
Kitley J; Leite MI; Nakashima I; Waters P; McNeillis B; Brown R; Takai Y; Takahashi T; Misu T; Elsone L; Woodhall M; George J; Boggild M; Vincent A; Jacob A; Fujihara K; Palace J
Brain; 2012 Jun; 135(Pt 6):1834-49. PubMed ID: 22577216
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics of very late-onset neuromyelitis optica spectrum disorder.
Cai LJ; Zhang Q; Zhang Y; Chen HX; Shi ZY; Du Q; Zhou HY
Mult Scler Relat Disord; 2020 Nov; 46():102515. PubMed ID: 33032051
[TBL] [Abstract][Full Text] [Related]
24. Neuromyelitis Optica Spectrum Disorders.
Akaishi T; Nakashima I; Sato DK; Takahashi T; Fujihara K
Neuroimaging Clin N Am; 2017 May; 27(2):251-265. PubMed ID: 28391784
[TBL] [Abstract][Full Text] [Related]
25. Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype.
Pröbstel AK; Rudolf G; Dornmair K; Collongues N; Chanson JB; Sanderson NS; Lindberg RL; Kappos L; de Seze J; Derfuss T
J Neuroinflammation; 2015 Mar; 12():46. PubMed ID: 25889963
[TBL] [Abstract][Full Text] [Related]
26. Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD.
Yan Y; Li Y; Fu Y; Yang L; Su L; Shi K; Li M; Liu Q; Borazanci A; Liu Y; He Y; Bennett JL; Vollmer TL; Shi FD
Sci China Life Sci; 2016 Dec; 59(12):1270-1281. PubMed ID: 26920678
[TBL] [Abstract][Full Text] [Related]
27. Late-onset neuromyelitis optica spectrum disorder in AQP4-seropositivepatients in a Chinese population.
Mao Z; Yin J; Zhong X; Zhao Z; Qiu W; Lu Z; Hu X
BMC Neurol; 2015 Sep; 15():160. PubMed ID: 26337073
[TBL] [Abstract][Full Text] [Related]
28. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
[TBL] [Abstract][Full Text] [Related]
29. Is pruritus an indicator of aquaporin-positive neuromyelitis optica?
Netravathi M; Saini J; Mahadevan A; Hari-Krishna B; Yadav R; Pal PK; Satishchandra P
Mult Scler; 2017 May; 23(6):810-817. PubMed ID: 27540000
[TBL] [Abstract][Full Text] [Related]
30. Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort: Demographic, Clinical, and Laboratory Features.
Altintas A; Karabudak R; Balci BP; Terzi M; Soysal A; Saip S; Tuncer Kurne A; Uygunoglu U; Nalbantoglu M; Gozubatik Celik G; Isik N; Celik Y; Gokcay F; Duman T; Boz C; Yucesan C; Mangan MS; Celebisoy N; Diker S; Colpak Isikay I; Kansu T; Siva A
Neurologist; 2015 Oct; 20(4):61-6. PubMed ID: 26468870
[TBL] [Abstract][Full Text] [Related]
31. Features of anti-aquaporin 4 antibody-seropositive Chinese patients with neuromyelitis optica spectrum optic neuritis.
Li H; Wang Y; Xu Q; Zhang A; Zhou H; Zhao S; Kang H; Peng C; Cao S; Wei S
J Neurol; 2015 Oct; 262(10):2293-304. PubMed ID: 26162715
[TBL] [Abstract][Full Text] [Related]
32. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
[TBL] [Abstract][Full Text] [Related]
33. Expression and Clinical Correlation Analysis Between Repulsive Guidance Molecule a and Neuromyelitis Optica Spectrum Disorders.
Tang J; Zeng X; Yang J; Zhang L; Li H; Chen R; Tang S; Luo Y; Qin X; Feng J
Front Immunol; 2022; 13():766099. PubMed ID: 35185873
[TBL] [Abstract][Full Text] [Related]
34. Neuromyelitis Optica spectrum disorders in Argentina: A hospital-based study.
Villa AM; Manin A; Seimandi C; Finkelsteyn AM; Ramos G; Tenembaum S
Mult Scler Relat Disord; 2023 Nov; 79():105018. PubMed ID: 37806234
[TBL] [Abstract][Full Text] [Related]
35. Presence of anti-Ro/SSA antibody may be associated with anti-aquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder.
Park JH; Hwang J; Min JH; Kim BJ; Kang ES; Lee KH
J Neurol Sci; 2015 Jan; 348(1-2):132-5. PubMed ID: 25500159
[TBL] [Abstract][Full Text] [Related]
36. Neuromyelitis optica in Portugal (NEMIPORT) - A multicentre study.
Domingos J; Isidoro L; Figueiredo R; Brum M; Capela C; Barros P; Santos E; Macário Mdo C; Pinto Marques J; Pedrosa R; Vale J; Sá MJ
Clin Neurol Neurosurg; 2015 Jul; 134():79-84. PubMed ID: 25965287
[TBL] [Abstract][Full Text] [Related]
37. Predictive value of conventional MRI parameters in first spinal attacks of neuromyelitis optica spectrum disorder.
Bonnan M; Debeugny S; Mejdoubi M; Cabre P
Mult Scler; 2020 Apr; 26(4):468-475. PubMed ID: 30843448
[TBL] [Abstract][Full Text] [Related]
38. Contribution of spinal cord biopsy to diagnosis of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.
Ringelstein M; Metz I; Ruprecht K; Koch A; Rappold J; Ingwersen J; Mathys C; Jarius S; Brück W; Hartung HP; Paul F; Aktas O;
Mult Scler; 2014 Jun; 20(7):882-8. PubMed ID: 24192218
[TBL] [Abstract][Full Text] [Related]
39. Clinical Features of Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders.
Chen H; Liu SM; Zhang XX; Liu YO; Li SZ; Liu Z; Dong HQ
Chin Med J (Engl); 2016 Sep; 129(17):2079-84. PubMed ID: 27569235
[TBL] [Abstract][Full Text] [Related]
40. Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion length and presence of symptomatic brain lesions.
Mealy MA; Mossburg SE; Kim SH; Messina S; Borisow N; Lopez-Gonzalez R; Ospina JP; Scheel M; Yeshokumar AK; Awad A; Leite MI; Arango JJ; Paul F; Palace J; Kim HJ; Levy M
Mult Scler Relat Disord; 2019 Feb; 28():64-68. PubMed ID: 30554040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
